Literature DB >> 30355197

Ischemic Stroke Increases Heart Vulnerability to Ischemia-Reperfusion and Alters Myocardial Cardioprotective Pathways.

Alexandre Meloux1,2, Eve Rigal1, Luc Rochette1, Yves Cottin1,2, Yannick Bejot1,3, Catherine Vergely1.   

Abstract

Background and Purpose- For years, the relationship between cardiac and neurological ischemic events has been limited to overlapping pathophysiological mechanisms and common risk factors. However, acute stroke may induce dramatic changes in cardiovascular function. The aim of this study was to evaluate how prior cerebrovascular lesions affect myocardial function and signaling in vivo and ex vivo and how they influence cardiac vulnerability to ischemia-reperfusion injury. Methods- Cerebral embolization was performed in adult Wistar male rats through the injection of microspheres into the left or right internal carotid artery. Stroke lesions were evaluated by microsphere counting, tissue staining, and assessment of neurological deficit 2 hours, 24 hours, and 7 days after surgery. Cardiac function was evaluated in vivo by echocardiography and ex vivo in isolated perfused hearts. Heart vulnerability to ischemia-reperfusion injury was investigated ex vivo at different times post-embolization and with varying degrees of myocardial ischemia. Left ventricles (LVs) were analyzed with Western blotting and quantitatve real-time polymerase chain reaction. Results- Our stroke model produced large cerebral infarcts with severe neurological deficit. Cardiac contractile dysfunction was observed with an early but persistent reduction of LV fractional shortening in vivo and of LV developed pressure ex vivo. Moreover, after 20 or 30 minutes of global cardiac ischemia, recovery of contractile function was poorer with impaired LV developed pressure and relaxation during reperfusion in both stroke groups. Following stroke, circulating levels of catecholamines and GDF15 (growth differentiation factor 15) increased. Cerebral embolization altered nitro-oxidative stress signaling and impaired the myocardial expression of ADRB1 (adrenoceptor β1) and cardioprotective Survivor Activating Factor Enhancement signaling pathways. Conclusions- Our findings indicate that stroke not only impairs cardiac contractility but also worsens myocardial vulnerability to ischemia. The underlying molecular mechanisms of stroke-induced myocardial alterations after cerebral embolization remain to be established, insofar as they may involve the sympathetic nervous system and nitro-oxidative stress.

Entities:  

Keywords:  autonomic nervous system; brain; heart; myocardial ischemia; stroke

Mesh:

Substances:

Year:  2018        PMID: 30355197     DOI: 10.1161/STROKEAHA.118.022207

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  Macrophage-NLRP3 Inflammasome Activation Exacerbates Cardiac Dysfunction after Ischemic Stroke in a Mouse Model of Diabetes.

Authors:  Hong-Bin Lin; Guan-Shan Wei; Feng-Xian Li; Wen-Jing Guo; Pu Hong; Ya-Qian Weng; Qian-Qian Zhang; Shi-Yuan Xu; Wen-Bin Liang; Zhi-Jian You; Hong-Fei Zhang
Journal:  Neurosci Bull       Date:  2020-07-18       Impact factor: 5.203

2.  Elevated serum growth differentiation factor 15 in multiple system atrophy patients: A case control study.

Authors:  Tao Yue; Hui Lu; Xiao-Mei Yao; Xia Du; Ling-Ling Wang; Dan-Dan Guo; Yi-Ming Liu
Journal:  World J Clin Cases       Date:  2020-06-26       Impact factor: 1.337

Review 3.  Cerebral-Cardiac Syndrome and Diabetes: Cardiac Damage After Ischemic Stroke in Diabetic State.

Authors:  Hong-Bin Lin; Feng-Xian Li; Jin-Yu Zhang; Zhi-Jian You; Shi-Yuan Xu; Wen-Bin Liang; Hong-Fei Zhang
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561

4.  Temporal alteration of microglia to microinfarcts in rat brain induced by the vascular occlusion with fluorescent microspheres.

Authors:  Yi Shen; Jingjing Cui; Shuang Zhang; Yuqing Wang; Jia Wang; Yuxin Su; Dongsheng Xu; Yihan Liu; Yating Guo; Wanzhu Bai
Journal:  Front Cell Neurosci       Date:  2022-08-03       Impact factor: 6.147

Review 5.  Systemic inflammation after stroke: implications for post-stroke comorbidities.

Authors:  Alba Simats; Arthur Liesz
Journal:  EMBO Mol Med       Date:  2022-08-15       Impact factor: 14.260

Review 6.  Stroke-Heart Syndrome: Recent Advances and Challenges.

Authors:  Jan F Scheitz; Luciano A Sposato; Jeanette Schulz-Menger; Christian H Nolte; Johannes Backs; Matthias Endres
Journal:  J Am Heart Assoc       Date:  2022-09-03       Impact factor: 6.106

7.  The construction of neurogenesis-related ceRNA network of ischemic stroke treated by oxymatrine.

Authors:  Xiaoling Zhang; Wentao Yao; Wannian Zhao; Yingru Sun; Zongkai Wu; Weiliang He; Yingxiao Ji; Yaran Gao; Xiaoli Niu; Litao Li; Hebo Wang
Journal:  Neuroreport       Date:  2022-09-07       Impact factor: 1.703

Review 8.  Leonurine, a potential drug for the treatment of cardiovascular system and central nervous system diseases.

Authors:  Lu Huang; Ding-Qiao Xu; Yan-Yan Chen; Shi-Jun Yue; Yu-Ping Tang
Journal:  Brain Behav       Date:  2020-12-10       Impact factor: 3.405

9.  Metoprolol Impairs β1-Adrenergic Receptor-Mediated Vasodilation in Rat Cerebral Arteries: Implications for β-Blocker Therapy.

Authors:  Christopher L Moore; David S Henry; Samantha J McClenahan; Kelly K Ball; Nancy J Rusch; Sung W Rhee
Journal:  J Pharmacol Exp Ther       Date:  2020-10-25       Impact factor: 4.030

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.